Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,851 papers from all fields of science
Search
Sign In
Create Free Account
zolpidem
Known as:
N,N,6-trimethyl-2-(4-methylphenyl)imidazo(1,2a)pyridine-3-acetamide hemitartrate
, ZPD
, zolpidem [Chemical/Ingredient]
Expand
A drug used to treat insomnia (inability to sleep), and anxiety. It is a type of imidazopyridine (sedative hypnotic).
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
23 relations
Narrower (4)
Ambien
Intermezzo
Zolpidem tartrate 10 MG Oral Tablet
Zolpimist
Central Nervous System Depression [PE]
Drug Allergy
GABA B Agonists [MoA]
Pyridines
Expand
Broader (2)
GABA-A Receptor Agonists
Hypnotics and Sedatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone, in blood, urine, and hair.
M. Laloup
,
María del Mar Ramírez Fernández
,
G. de Boeck
,
M. Wood
,
V. Maes
,
N. Samyn
Journal of Analytical Toxicology
2005
Corpus ID: 36298531
A liquid chromatography-tandem mass spectrometry method was developed for the simultaneous quantification of 26 benzodiazepines…
Expand
Highly Cited
2004
Highly Cited
2004
'Hypnotic' prescription patterns in a large managed-care population.
T. Roehrs
,
T. Roth
Sleep Medicine
2004
Corpus ID: 25887899
Review
2000
Review
2000
Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report.
Massimiliano Aragona
Clinical neuropharmacology
2000
Corpus ID: 25803075
The imidazopyridine zolpidem is a short-acting hypnotic chemically distinct from benzodiazepines (BZs). According to its peculiar…
Expand
Highly Cited
1999
Highly Cited
1999
Zolpidem in progressive supranuclear palsy.
A. Daniele
,
E. Moro
,
A. Bentivoglio
New England Journal of Medicine
1999
Corpus ID: 35362142
To the Editor: Progressive supranuclear palsy is an atypical Parkinsonian syndrome characterized by motor symptoms (voluntary-eye…
Expand
Highly Cited
1998
Highly Cited
1998
GABAA receptor function in epileptic human dentate granule cells: comparison to epileptic and control rat
M. Shumate
,
D. D. Lin
,
J. Gibbs
,
K. Holloway
,
D. Coulter
Epilepsy Research
1998
Corpus ID: 13676081
Highly Cited
1996
Highly Cited
1996
Enantioselective determination of zopiclone and its metabolites in urine by capillary electrophoresis.
G. Hempel
,
G. Blaschke
Journal of chromatography. B, Biomedical…
1996
Corpus ID: 29206282
Highly Cited
1996
Highly Cited
1996
Zolpidem-induced psychosis.
John S. Markowitz
,
T. Brewerton
Annals of clinical psychiatry : official journal…
1996
Corpus ID: 26405021
Zolpidem is reported to be a safe and effective hypnotic agent for the short-term treatment of insomnia. There are several case…
Expand
Highly Cited
1996
Highly Cited
1996
Effect of zolpidem on sleep and ventilatory patterns at simulated altitude of 4,000 meters.
M. Beaumont
,
Françoise Goldenberg
,
D. Lejeune
,
Henri Marotte
,
Alain Harf
,
F. Lofaso
American Journal of Respiratory and Critical Care…
1996
Corpus ID: 25837594
The purpose of this study was to assess the effect of zolpidem 1 0 mg, a new imidazopyridine hypnotic drug, on sleep and…
Expand
Highly Cited
1993
Highly Cited
1993
Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
M. Roger
,
P. Attali
,
Coquelin Jp
Clinical Therapeutics
1993
Corpus ID: 10121477
The efficacy and safety of zolpidem, a hypnotic of a new chemical class (the imidazopyridines), was compared with a reference…
Expand
Review
1988
Review
1988
Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum
C. Gardner
Progress in neurobiology
1988
Corpus ID: 39183329
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE